Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

ALZHEIMER'S DISEASE AND INOSITOL

"Inositol Treatment of Alzheimer's Disease: A Double-Blind, Cross-Over Placebo Controlled Trial"

Barak, Yoram, et al, Prog. Neuro-Psychopharmacol. and Biological Psychiatry, 1996;20:729-735.

In a double-blind crossover study, inositol at 6 grams per day versus glucose for 1 month each was carried out in 11 Alzheimer's disease patients. There was an overall improvement in the Cognitive Subscale of the Cambridge Mental Disorder of the Elderly Examination (CAMDEX) with inositol but it was not significant. Language and orientation improved significantly more with inositol than the placebo. There were no serious side effects. The authors feel that higher doses of inositol should be studied in Alzheimer's disease patients for longer periods of time.

Find us on Facebook Dr. Rath Health Foundation on Twitter Dr. Rath Health Foundation Offical YouTube Channel

Page Tools: